Bluestem Biosciences

Omaha, NE · Founded 2022 · Privately Held (backing)

Developer of a digital biology platform designed to build biology for strategic opportunities around agriculture and infrastructure. Bluestem Biosciences is based in Omaha, NE and was founded in 2022. It was valued at $135 million at its seed round in Dec 2025, the last priced event on record. It has raised $21 million across 1 recorded round; the latest was a $5 million early-stage round in Jul 2022.

PMV mark · valuation
$135.0M
Oct 2026
Priced at
its seed round
Dec 2025
Total raised
$21.0M
Last round
Early Stage VC
Jul 2022
What is Bluestem Biosciences worth?
$135.0MPrivateMarketView mark · Oct 2026

Valued at $135.0M at its seed round, Dec 2025. Nothing has traded since.

Free account
More of Bluestem Biosciences with a free account
  • ·Watch Bluestem Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Bluestem Biosciences funding history

1 rounds
DateRoundRaisedPost-money
Jul 2022Early Stage VC$5.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Bluestem Biosciences valuation

Bluestem Biosciences was valued at $135 million at its seed round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Bluestem Biosciences raised?

Bluestem Biosciences has raised $21 million in total; 1 of its rounds is on record. The largest on record was a $5 million early-stage round in Jul 2022.

Bluestem Biosciences has filed 1 Form D with the SEC, most recently in Aug 2022 ($5 million sold to 19 investors).

How Bluestem Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Bluestem Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Bluestem Biosciences

What is Bluestem Biosciences worth?
Bluestem Biosciences is valued at $135.0M as of Oct 2026. Valued at $135.0M at its seed round, Dec 2025. Nothing has traded since.
How much has Bluestem Biosciences raised?
Bluestem Biosciences has raised $21.0M in total funding across 1 recorded rounds.
When did Bluestem Biosciences last raise?
Bluestem Biosciences last raised in Jul 2022 (Early Stage VC), raising $5.0M.